DNA-based vaccines offer a clever extra step in the development of those antibodies by removing the middle step. Rather than introducing an element that triggers our body to (hopefully) produce...
How a COVID-19 DNA Vaccine Works
entos
Entos Pharma Announces Lead Vaccines, $4.2M Funding for PI/II Trials
Entos Pharmaceuticals (Entos), a healthcare biotechnology company developing nucleic acid medicines with its Fusogenix drug delivery platform, today announced the selection of two lead candidates for a pan-coronavirus Fusogenix DNA vaccine (Covigenix)